Order Article Reprints

Jiang G, Teramoto Y, Goto T, Mizushima T, Inoue S, Ide H, Nagata Y, Kashiwagi E, Baras AS, Netto GJ, et al. Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer. Cancers. 2021; 13(5):975. https://doi.org/10.3390/cancers13050975

Jiang, Guiyang, Yuki Teramoto, Takuro Goto, Taichi Mizushima, Satoshi Inoue, Hiroki Ide, Yujiro Nagata, Eiji Kashiwagi, Alexander S. Baras, George J. Netto, and et al. 2021. "Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer" Cancers 13, no. 5: 975. https://doi.org/10.3390/cancers13050975

Jiang, G., Teramoto, Y., Goto, T., Mizushima, T., Inoue, S., Ide, H., Nagata, Y., Kashiwagi, E., Baras, A. S., Netto, G. J., Yang, Z., & Miyamoto, H. (2021). Identification of BXDC2 as a Key Downstream Effector of the Androgen Receptor in Modulating Cisplatin Sensitivity in Bladder Cancer. Cancers, 13(5), 975. https://doi.org/10.3390/cancers13050975